Skip to main content

Table 4 Cardiovascular events and all-cause and cardiovascular mortality by tertiles of flavonoid intake (the first the lower; the third, the higher)

From: Dietary flavonoid intake and cardiovascular risk: a population-based cohort study

 

First tertile

Second tertile

Third tertile

Total flavonoids

 Incident CV events

54

40

  

31

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.65

0.42–0.99

0.05

0.45

0.28–0.73

0.001

  Model 2

1

0.64

0.42–1.00

0.05

0.46

0.28–0.75

0.002

 CV mortality

34

26

  

24

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.97

0.56–1.67

0.90

0.81

0.45–1.44

0.47

  Model 2

1

0.95

0.54–1.66

0.85

0.83

0.46–1.51

0.55

 All-cause mortality

89

69

  

62

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.86

0.62–1.21

0.38

0.73

0.51–1.04

0.08

  Model 2

1

0.90

0.65–1.26

0.52

0.78

0.55–1.13

0.19

Proanthocyanids

 Incident CV events

57

37

  

31

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.56

0.36–0.86

0.01

0.42

0.26–0.68

<0.001

  Model 2

1

0.56

0.36–0.87

0.009

0.43

0.27–0.70

0.001

 CV mortality

34

27

  

23

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.99

0.58–1.70

0.97

0.77

0.43–1.39

0.39

  Model 2

1

0.98

0.56–1.69

0.93

0.80

0.44–1.46

0.46

 All-cause mortality

90

70

  

60

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.85

0.61–1.19

0.35

0.69

0.48–0.99

0.05

  Model 2

1

0.88

0.63–1.24

0.46

0.75

0.52–1.08

0.12

Flavan-3-ols

 Incident CV events

57

42

  

26

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.69

0.46–1.05

0.08

0.40

0.25–0.65

<0.001

  Model 2

1

0.71

0.47–1.08

0.11

0.42

0.26–0.68

<0.001

 CV mortality

37

23

  

24

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.75

0.44–1.29

0.30

0.70

0.40–1.20

0.19

  Model 2

1

0.79

0.46–1.37

0.40

0.72

0.41–1.26

0.25

 All-cause mortality

92

71

  

57

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.84

0.61–1.15

0.27

0.63

0.44–0.89

0.009

  Model 2

1

0.86

0.62–1.19

0.36

0.68

0.48–0.96

0.03

Anthocyanidins

 Incident CV events

53

35

  

37

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.59

0.38–0.92

0.02

0.58

0.37–0.92

0.02

  Model 2

1

0.58

0.37–0.91

0.02

0.56

0.36–0.89

0.02

 CV mortality

40

20

  

24

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.58

0.33–1.01

0.05

0.65

0.37–1.15

0.14

  Model 2

1

0.56

0.32–0.98

0.04

0.67

0.38–1.18

0.16

 All-cause mortality

95

62

  

63

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.69

0.50–0.96

0.03

0.66

0.47–0.94

0.02

  Model 2

1

0.66

0.47–0.94

0.02

0.66

0.46–0.95

0.02

Flavanones

 Incident CV events

54

42

  

29

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.71

0.47–1.07

0.11

0.45

0.28–0.73

0.001

  Model 2

1

0.73

0.48–1.10

0.13

0.48

0.29–0.77

0.003

 CV mortality

39

24

  

21

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.67

0.40–1.13

0.14

0.56

0.32–0.99

0.05

  Model 2

1

0.71

0.42–1.20

0.20

0.66

0.37–1.17

0.15

 All-cause mortality

91

80

  

49

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.91

0.67–1.24

0.54

0.54

0.37–0.78

0.001

  Model 2

1

0.94

0.68–1.29

0.69

0.59

0.40–0.85

0.005

Flavonols

 Incident CV events

56

31

  

38

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.49

0.31–0.76

0.002

0.53

0.34–0.83

0.006

  Model 2

1

0.51

0.32–0.80

0.003

0.53

0.34–0.83

0.005

 CV mortality

36

22

  

26

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.63

0.36–1.09

0.10

0.68

0.39–1.19

0.18

  Model 2

1

0.69

0.40–1.20

0.19

0.72

0.41–1.27

0.26

 All-cause mortality

91

64

  

65

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.72

0.51–1.00

0.05

0.70

0.50–0.99

0.05

  Model 2

1

0.78

0.55–1.08

0.14

0.72

0.51–1.02

0.06

Flavones

 Incident CV events

42

51

  

32

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

1.13

0.74–1.72

0.56

0.68

0.41–1.10

0.11

  Model 2

1

1.14

0.75–1.75

0.54

0.66

0.40–1.09

0.10

 CV mortality

30

31

  

23

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

1.08

0.64–1.82

0.77

0.87

0.48–1.56

0.63

  Model 2

1

1.10

0.65–1.87

0.72

0.83

0.45–1.52

0.55

 All-cause mortality

88

71

  

61

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.79

0.57–1.09

0.16

0.71

0.50–1.01

0.06

  Model 2

1

0.83

0.60–1.16

0.28

0.73

0.51–1.05

0.09

Isoflavones

 Incident CV events

48

38

  

39

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.78

0.51–1.20

0.26

0.77

0.49–1.19

0.23

  Model 2

1

0.81

0.53–1.25

0.35

0.77

0.49–1.21

0.26

 CV mortality

30

34

  

20

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

1.23

0.74–2.03

0.42

0.78

0.44–1.41

0.42

  Model 2

1

1.21

0.73–2.02

0.48

0.74

0.41–1.36

0.34

 All-cause mortality

95

63

  

62

  
 

HR

HR

95% CI

P

HR

95% CI

P

  Model 1

1

0.68

0.49–0.94

0.02

0.70

0.50–0.98

0.04

  Model 2

1

1.45

1.05–2.00

0.03

1.39

1.00–1.95

0.05

  1. Model 1 adjusted for age, sex, BMI, education, living in a rural area, METs (h/week), fiber and saturated fatty acid intakes, Model 2 adjusted for age, sex, BMI, education, living in a rural area, METs (hour/week), fiber, and saturated fatty acid intakes, alcohol intake, smoking, values of systolic and diastolic blood pressure, total and HDL-cholesterol, fasting glucose, CRP, statin and aspirin use.